45
ORF Biologics, Inc. raises $2.5M under Reg D
Company raise · Pre-first close · Offering $2.5M · CORALVILLE, IA · filed 2024-12-12
40
ORF Biologics, Inc. raises $1.7M under Reg D
Company raise · Raising · TIFFIN, IA · Form D filed 2026-07-31
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Jay Kamath | Executive Officer |
| Sara Ternes | Executive Officer |
| Roger A. Baker | Director |
| Anant Kamath | Executive Officer, Director |
| Nicholas Taiber | Director |
| John R. Huiskamp | Director |
| Steven Michalicek | Director |
Signed by Anant Kamath, CEO.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.